KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-Current Deferred Tax Liability (2020 - 2025)

AbCellera Biologics' Non-Current Deferred Tax Liability history spans 6 years, with the latest figure at $9.7 million for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deferred Tax Liability fell 23.76% year-over-year to $9.7 million, compared with a TTM value of $9.7 million through Sep 2025, down 23.76%, and an annual FY2024 reading of $63.7 million, up 108.04% over the prior year.
  • Non-Current Deferred Tax Liability for Q3 2025 was $9.7 million at AbCellera Biologics, down from $10.1 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $63.7 million in Q4 2024, with the low at $9.7 million in Q3 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $30.6 million, with a median of $33.2 million recorded in 2023.
  • Year-over-year, Non-Current Deferred Tax Liability skyrocketed 108.04% in 2024 and then crashed 66.79% in 2025.
  • Tracing ABCL's Non-Current Deferred Tax Liability over 5 years: stood at $37.4 million in 2021, then skyrocketed by 65.68% to $61.9 million in 2022, then plummeted by 50.56% to $30.6 million in 2023, then skyrocketed by 108.04% to $63.7 million in 2024, then crashed by 84.7% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Non-Current Deferred Tax Liability are $9.7 million (Q3 2025), $10.1 million (Q2 2025), and $10.1 million (Q1 2025).